Antibody Response to COVID-19 mRNA Vaccines in Oncologic and Hematologic Patients Undergoing Chemotherapy.

Manlio MencoboniVincenzo FontanaAzzurra DamianiAntonino SpitaleriAlessandro RasoLuigi Carlo BottaroGiovanni RossiLuciano CanobbioAntonella La CameraRosa Angela FilibertiPaola TaveggiaAlessia Cavo

Published in: Current oncology (Toronto, Ont.) (2022)

the response to vaccination is similar in patients affected by solid tumors to controls. On the contrary, hemolymphopietic patients show a much lower response than controls.

Keyphrases

end stage renal disease
patients undergoing
newly diagnosed
ejection fraction
chronic kidney disease
sars cov
prognostic factors
coronavirus disease
peritoneal dialysis
squamous cell carcinoma
radiation therapy
rectal cancer
radical prostatectomy
locally advanced